|
|
|
Insider
Information: |
Mott David M |
Relationship: |
Director |
City: |
Gaithersburg |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
36 |
|
Direct
Shares |
6,137,361 |
|
Indirect Shares
|
266,283,930 |
|
|
Direct
Value |
$8,800,265 |
|
|
Indirect Value
|
$1,035,299,275 |
|
|
Total
Shares |
272,421,291 |
|
|
Total
Value |
$1,044,099,540 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
134.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Medimmune Inc |
MEDI |
Vice Chairman, CEO & P... |
2007-06-01 |
0 |
2003-09-15 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2013-06-03 |
575 |
Premium* |
|
Millennial Media Inc |
MM |
10% Owner |
2012-04-03 |
0 |
2012-10-29 |
8,196,614 |
Premium* |
|
Tesaro, Inc. |
TSRO |
Director, 10% Owner |
2019-01-22 |
0 |
2019-01-22 |
0 |
Premium* |
|
Workday, Inc. |
WDAY |
10% Owner |
2013-04-09 |
0 |
2013-04-09 |
1,171 |
Premium* |
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
Epizyme, Inc. |
EPZM |
Director |
2022-08-12 |
0 |
2022-08-12 |
0 |
Premium* |
|
Care.com Inc |
CRCM |
10% Owner |
2014-01-29 |
0 |
2017-11-06 |
2,302 |
Premium* |
|
Roka Bioscience, Inc. |
ROKA |
10% Owner |
|
0 |
2014-07-22 |
3,216,810 |
Premium* |
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
Box Inc |
BOX |
10% Owner |
|
0 |
2015-01-28 |
0 |
Premium* |
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
Ardelyx Inc |
ARDX |
Director |
2024-06-14 |
1,209,597 |
2019-12-09 |
6,564,372 |
Premium* |
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
Adaptimmune Therapeutics PLC |
ADAP |
Director, 10% Owner |
|
0 |
2020-01-24 |
102,478,668 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2019-04-08 |
25,243,865 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
Mersana Therapeutics, Inc. |
MRSN |
Director |
2024-01-02 |
588,694 |
2024-01-02 |
9,595 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2019-05-07 |
2,052,454 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,312,877 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
2017-10-10 |
0 |
2017-10-10 |
4,909,956 |
Premium* |
|
Appian Corp |
APPN |
10% Owner |
2017-11-20 |
0 |
2018-02-13 |
2,031 |
Premium* |
|
Elastic N.v. |
ESTC |
10% Owner |
2018-10-10 |
0 |
2018-10-10 |
2,197,503 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2019-06-24 |
7,225,676 |
Premium* |
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2019-05-09 |
4,438,562 |
Premium* |
|
Nightstar Therapeutics Plc |
NITE |
Director, 10% Owner |
2019-06-07 |
0 |
2019-06-07 |
0 |
Premium* |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
4,186,243 |
Premium* |
|
Cloudflare, Inc. |
NET |
10% Owner |
2019-09-17 |
4,059,376 |
2019-09-17 |
0 |
Premium* |
|
Novavax Inc |
NVAX |
|
2024-06-12 |
50,470 |
|
0 |
Premium* |
|
Enliven Therapeutics Ord Shs |
ELVN |
Director |
2022-02-23 |
229,224 |
2022-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
223 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SURF |
Surface Oncology, Inc. |
10% Owner |
|
2018-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
3,179,544 |
3,179,544 |
0 |
- |
|
MULE |
Mulesoft, Inc |
10% Owner |
|
2018-05-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(16,115,887) |
0 |
0 |
- |
|
MULE |
Mulesoft, Inc |
10% Owner |
|
2018-05-01 |
4 |
A |
$0.00 |
$0 |
I/I |
16,115,887 |
858,978 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-05-08 |
4 |
B |
$2.13 |
$151,250 |
I/I |
70,873 |
17,354,543 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-05-17 |
4 |
B |
$2.13 |
$391,436 |
I/I |
184,179 |
17,538,722 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-05-18 |
4 |
B |
$2.14 |
$42,928 |
I/I |
20,100 |
17,558,822 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-05-21 |
4 |
B |
$2.14 |
$69,059 |
I/I |
32,200 |
17,591,022 |
1.5 |
- |
|
ARDX |
Ardelyx Inc |
Director |
|
2018-05-25 |
4 |
A |
$4.00 |
$3,333,332 |
I/I |
833,333 |
3,082,186 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-05-30 |
4 |
B |
$2.15 |
$591 |
I/I |
275 |
17,591,297 |
1.42 |
- |
|
TSRO |
Tesaro, Inc. |
Director |
|
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,537 |
15,362 |
0 |
- |
|
ARDX |
Ardelyx Inc |
Director |
|
2018-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
20,843 |
54,720 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-06-27 |
4 |
B |
$2.15 |
$11,384 |
I/I |
5,295 |
17,596,592 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-06-28 |
4 |
B |
$2.10 |
$392,692 |
I/I |
187,130 |
17,783,722 |
1.5 |
- |
|
EPZM |
Epizyme, Inc. |
Director |
|
2018-07-02 |
4 |
A |
$13.55 |
$82,492 |
D/D |
6,088 |
12,088 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-07-18 |
4 |
B |
$1.95 |
$390,580 |
I/I |
200,000 |
17,983,722 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-07-19 |
4 |
B |
$2.00 |
$101,165 |
I/I |
50,600 |
18,034,322 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-08-21 |
4 |
B |
$2.26 |
$1,499,998 |
I/I |
663,716 |
18,698,038 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
Director |
|
2018-09-07 |
4 |
B |
$1.67 |
$25,000,500 |
I/I |
15,000,000 |
12,000,000 |
2.25 |
- |
|
EPZM |
Epizyme, Inc. |
Director |
|
2018-10-05 |
4 |
B |
$9.00 |
$3,750,003 |
I/I |
416,667 |
6,471,018 |
2.1 |
- |
|
ESTC |
Elastic N.v. |
10% Owner |
|
2018-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
5,684,112 |
1,528,117 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-11-15 |
4 |
B |
$1.86 |
$631,958 |
I/I |
340,000 |
19,038,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-11-16 |
4 |
B |
$1.86 |
$649,355 |
I/I |
350,000 |
19,388,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-11-19 |
4 |
B |
$1.88 |
$956,658 |
I/I |
510,000 |
19,898,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-11-20 |
4 |
B |
$1.98 |
$336,107 |
I/I |
170,000 |
20,068,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-11-28 |
4 |
B |
$1.99 |
$48,824 |
I/I |
24,500 |
20,092,538 |
1.5 |
- |
|
223 Records found
|
|
Page 5 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|